Back to Search Start Over

Interferon-Tau has Antiproliferative effects, Represses the Expression of E6 and E7 Oncogenes, Induces Apoptosis in Cell Lines Transformed with HPV16 and Inhibits Tumor Growth In Vivo .

Authors :
Padilla-Quirarte HO
Trejo-Moreno C
Fierros-Zarate G
Castañeda JC
Palma-Irizarry M
Hernández-Márquez E
Burguete-Garcia AI
Peralta-Zaragoza O
Madrid-Marina V
Torres-Poveda K
Bermúdez-Morales VH
Source :
Journal of Cancer [J Cancer] 2016 Nov 05; Vol. 7 (15), pp. 2231-2240. Date of Electronic Publication: 2016 Nov 05 (Print Publication: 2016).
Publication Year :
2016

Abstract

Interferon tau (IFN-τ) is a promising alternative antiviral and immunotherapeutic agent in a wide variety of diseases including infectious, neurodegenerative, autoimmune and cancer due to its low toxicity in comparison with other type I interferon´s. The objective of our study was established the effect of the bovine IFN-τ on human (SiHa) and murine (BMK-16/myc) cells transformed with HPV 16 and evaluates the antitumor effect in a murine tumor model HPV 16 positive. We determine that bovine IFN-τ has antiproliferative effects, pro-apoptotic activity and induces repression of viral E6 and E7 oncogenes (time- and dose-dependent) on human and murine cells transformed with HPV 16 similar to the effects of IFN-β. However, IFN-τ induces greater antiproliferative effect, apoptosis and repression of both oncogenes in BMK-16/myc cells compared to SiHa cells. The differences were explained by the presence and abundance of the type I interferon receptor (IFNAR) in each cell line. On the other hand, we treated groups of tumor-bearing mice (HPV16 positive) with IFN-τ and showed the inhibition tumor growth effect in vivo . Our finding indicates that bovine IFN-τ may be a good candidate for immunotherapy against cervical cancer.<br />Competing Interests: The authors declare no conflict of interest.

Details

Language :
English
ISSN :
1837-9664
Volume :
7
Issue :
15
Database :
MEDLINE
Journal :
Journal of Cancer
Publication Type :
Academic Journal
Accession number :
27994659
Full Text :
https://doi.org/10.7150/jca.15502